MKI67 and gastrointestinal stromal tumor: It is important to note, however, that while Ki-67 has been validated as a prognostic biomarker in GIST and correlates with overall and disease-free survival, it is not currently incorporated into standard risk stratification systems, which continue to rely primarily on mitotic count.